A strong thrust to the upside is, however, fraught with some caution, as the markets are now gearing up for some strong ...

Jefferies issues Buy ratings on Polycab, Torrent Pharma, and Ambuja Cements with up to 22% return potential - see if these stocks fit your portfolio!

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4% ...

The company earned a post-earnings recommendation upgrade from an analyst. Athletic apparel and footwear star Nike (NYSE: NKE ...

Five of the Buy picks have returned more than 20%, while two have lost at least that much. Click here to find out more ...

Discover why US stocks lost their edge in 2025, how gold and foreign equities excel, and why safer retirement strategies are ...

Historically, July has been a seasonally positive month for equities, and the current setup suggests the potential for this ...

According to the average brokerage recommendation (ABR), one should invest in Micron (MU). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...

SEBI plans amendments to InvIT and REIT regulations, streamlining definitions, cash flow adjustments, reporting timelines, and minimum allotment for ease of ...

Ric Edelman advises 10–40% crypto allocation, backing BTC as TradFi warms to digital assets despite lingering skepticism.

Netease Cloud Music’s financial position has improved since the company began generating free cash flow in 2022. By the end of 2024, Cloud Music held a net cash position of nearly CNY 12 billion, ...

Circle debuted this month at $69 per share in the first major IPO by a stablecoin issuer. The blockbuster flotation ...